Journal Information
Vol. 89. Issue 1.
Pages 4-5 (January - February 2013)
Share
Share
Download PDF
More article options
Vol. 89. Issue 1.
Pages 4-5 (January - February 2013)
Editorial
Open Access
Oral Ibuprofen and the Patent Ductus Arteriosus: A New Approach to an Old Problem
Ibuprofeno via oral e a persistência do canal arterial: uma nova abordagem para um problema antigo
Visits
5551
Martin Kluckow
Corresponding author
martin.kluckow@sydney.edu.au

Corresponding author.
Royal North Shore Hospital, Sydney, Australia. Associate Professor, University of Sydney, Australia
Related content
Eun Mi Yang, Eun Song Song, Young Youn Choi
This item has received

Under a Creative Commons license
Article information
Full text is only aviable in PDF
References
[1]
Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE. Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med. 1976;295:526-9.
[2]
M.A. Heymann, A.M. Rudolph, N.H. Silverman.
Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis.
N Engl J Med., 295 (1976), pp. 530-533
[3]
Patel J, Marks KA, Roberts I, Azzopardi D, Edwards AD. Ibuprofen treatment of patent ductus arteriosus. Lancet. 1995;346:255.
[4]
Dani C, Vangi V, Bertini G, Pratesi S, Lori I, Favelli F, et al. High- dose ibuprofen for patent ductus arteriosus in extremely preterm infants: a randomized controlled study. Clin Pharmacol Ther. 2012;91:590-6.
[5]
Yang E, Song ES, Choi Y. Comparison of oral ibuprofen and intravenous indomethacin for the treatment of patent ductus arteriosus in extremely low birth weight infants. J Pediatr (Rio J). 2013;89:33-9.
[6]
Erdeve O, Yurttutan S, Altug N, Ozdemir R, Gokmen T, Dilmen U, et al. Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 2012; 97:F279-83.
[7]
Fakhraee SH, Badiee Z, Mojtahedzadeh S, Kazemian M, Kelishadi R. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Zhongguo Dang Dai Er Ke Za Zhi. 2007;9:399-403.
[8]
H. Aly, W. Lotfy, N. Badrawi, M. Ghawas, I.E. Abdel-Meguid, T.A. Hammad.
Oral Ibuprofen and ductus arteriosus in premature infants: a randomized pilot study.
Am J Perinatol., 24 (2007), pp. 267-270
[9]
Chotigeat U, Jirapapa K, Layangkool T. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. J Med Assoc Thai. 2003;86: S563-9.
[10]
Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. J Med Assoc Thai. 2002;85:S1252-8.
[11]
Heyman E, Morag I, Batash D, Keidar R, Baram S, Berkovitch M. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study. Pediatrics. 2003;112:e354.
[12]
Gokmen T, Erdeve O, Altug N, Oguz SS, Uras N, Dilmen U. Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. J Pediatr. 2011;158:549-54.
[13]
Barzilay B, Youngster I, Batash D, Keidar R, Baram S, Goldman M, et al. Pharmacokinetics of oral ibuprofen for patent ductus arteriosus closure in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2012; 97:F116-9.
[14]
Hammerman C, Shchors I, Jacobson S, Schimmel MS, Bromiker R, Kaplan M, et al. Ibuprofen versus continuous indomethacin in premature neonates with patent ductus arteriosus: is the difference in the mode of administration? Pediatr Res. 2008; 64:291-7.
[15]
K. de Waal, M. Kluckow.
Functional echocardiography; from physiology to treatment.
Early Hum Dev., 86 (2010), pp. 149-154

Please, cite this article as: Kluckow M. Oral ibuprofen and the patent ductus arteriosus: a new approach to an old problem. J Pediatr (Rio J). 2013;89:4-5.

See paper by Yang EM et al. in pages 33-39.

Copyright © 2013. Sociedade Brasileira de Pediatria
Download PDF
Idiomas
Jornal de Pediatria (English Edition)
Article options
Tools
en pt
Taxa de publicaçao Publication fee
Os artigos submetidos a partir de 1º de setembro de 2018, que forem aceitos para publicação no Jornal de Pediatria, estarão sujeitos a uma taxa para que tenham sua publicação garantida. O artigo aceito somente será publicado após a comprovação do pagamento da taxa de publicação. Ao submeterem o manuscrito a este jornal, os autores concordam com esses termos. A submissão dos manuscritos continua gratuita. Para mais informações, contate assessoria@jped.com.br. Articles submitted as of September 1, 2018, which are accepted for publication in the Jornal de Pediatria, will be subject to a fee to have their publication guaranteed. The accepted article will only be published after proof of the publication fee payment. By submitting the manuscript to this journal, the authors agree to these terms. Manuscript submission remains free of charge. For more information, contact assessoria@jped.com.br.
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.